Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.

Patient drug sensitivity profiles were linked to their genomic mutation profiles and could provide prognostic and survival data.

Studies Demonstrate xCellSense® Platform's Ability to Predict Clinical Response and Enable Patient Stratification for Drug Development.

The next innovation in cancer treatment could be to test all possible drugs on thousands of miniature versions of a person’s tumour, grown in the lab, to see which works the best. The technique, ...

Despite many efforts to find better, more effective ways to treat cancer, it remains a leading cause of death by disease among children in the U.S. Despite advances in standard cancer treatments, many ...

Researchers have demonstrated that a functional precision medicine approach—combining artificial intelligence, DNA sequencing, mutation mapping and drug sensitivity testing—could feasibly help tackle ...

New research taking place at the University of Plymouth's Brain Tumour Research Centre of Excellence, and supported by the ...

Researchers led by teams at the University of California, Riverside (UCR), the University of California, Irvine, and the Yale School of Medicine have developed a compound that they found to be ...

Breast cancer is the most common cancer in U.S. women after skin cancer, according to the Centers for Disease Control and Prevention. Despite advances in standard cancer treatments, many cancer ...